These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19225353)

  • 1. Dosage variability of topical ocular hypotensive products: a densitometric assessment.
    Gaynes BI; Singa RM; Cao Y
    J Glaucoma; 2009 Feb; 18(2):149-52. PubMed ID: 19225353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of administration angle on the cost of artificial tear solutions: does bottle positioning minimize wastage?
    Gaynes BI; Singa RM; Schaab G; Sorokin Y
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):196-201. PubMed ID: 17444808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of drop size from multi-dose eye drop bottles: is it cause for concern?
    German EJ; Hurst MA; Wood D
    Eye (Lond); 1999; 13 ( Pt 1)():93-100. PubMed ID: 10396391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia.
    Al-Jumaian N; Malik R; Khandekar R; Al-Humaidan A; Al-Madany R; Al-Qahtani R; Altowairqi A; Al-Theeb A; Zaman B; Al-Djasim L; Craven ER; Edward DP
    Middle East Afr J Ophthalmol; 2016; 23(4):296-301. PubMed ID: 27994392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic study of factors affecting eye drop size and dosing variability.
    Sklubalová Z; Zatloukal Z
    Pharmazie; 2005 Dec; 60(12):917-21. PubMed ID: 16398268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squeeze Me if You Can: Variability in Force Requirements to Extract a Drop From Common Glaucoma Bottles.
    Moore DB; Hammer JD; Akhtari R; Beck J; Sanders S; Kryscio RJ
    J Glaucoma; 2016 Sep; 25(9):780-4. PubMed ID: 27552516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication.
    Salyani A; Birt C
    Can J Ophthalmol; 2005 Apr; 40(2):170-4. PubMed ID: 16049530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eye drop container delivery: a source of response variation?
    German EJ; Hurst MA; Wood D
    Ophthalmic Physiol Opt; 1997 May; 17(3):196-204. PubMed ID: 9196661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Utility of Cap Color and Bottle Characteristics for Topical Glaucoma Therapy.
    Marando CM; Seibold LK; SooHoo JR; Pantcheva MB; Ramulu PY; Kahook MY
    Ophthalmology; 2015 Dec; 122(12):2577-8. PubMed ID: 26077575
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of Eye Drop Instillation Before and After Use of Drop Application Strips in Glaucoma Patients on Chronic Topical Therapy.
    Sharma R; Singhal D; Shashni A; Agarwal E; Wadhwani M; Dada T
    J Glaucoma; 2016 Apr; 25(4):e438-40. PubMed ID: 26550965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Xal-Ease latanoprost delivery system.
    Semes L; Shaikh AS
    Optometry; 2007 Jan; 78(1):30-3. PubMed ID: 17208672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of eye drop size.
    Van Santvliet L; Ludwig A
    Surv Ophthalmol; 2004; 49(2):197-213. PubMed ID: 14998692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular hypotensive drugs.
    Willis AM
    Vet Clin North Am Small Anim Pract; 2004 May; 34(3):755-76. PubMed ID: 15110983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic versus brand-name North American topical glaucoma drops.
    Mammo ZN; Flanagan JG; James DF; Trope GE
    Can J Ophthalmol; 2012 Feb; 47(1):55-61. PubMed ID: 22333853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic glaucoma drop bottle cap colours.
    Hallaji NAE; Trope GE
    Can J Ophthalmol; 2016 Oct; 51(5):392-393. PubMed ID: 27769334
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient satisfaction with topical ocular hypotensives.
    Kerr NM; Patel HY; Chew SS; Ali NQ; Eady EK; Danesh-Meyer HV
    Clin Exp Ophthalmol; 2013; 41(1):27-35. PubMed ID: 22594958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to glaucoma drug delivery.
    Ghate D; Edelhauser HF
    J Glaucoma; 2008 Mar; 17(2):147-56. PubMed ID: 18344762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An objective assessment of the variability in number of drops per bottle of glaucoma medication.
    Moore DB; Beck J; Kryscio RJ
    BMC Ophthalmol; 2017 May; 17(1):78. PubMed ID: 28532424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observed time between prescription refills for newer ocular hypotensive agents: the effect of bottle size.
    Platt R; Reardon G; Mozaffari E
    Am J Ophthalmol; 2004 Jan; 137(1 Suppl):S17-23. PubMed ID: 14697911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction: new insights on enhancing adherence to topical glaucoma medications.
    Friedman DS
    Ophthalmology; 2009 Nov; 116(11 Suppl):S29. PubMed ID: 19837257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.